Comparing Treatment Strategies for Uncomplicated Diabetic Vitreous Hemorrhage: Medical Therapy versus Early Pars Plana Vitrectomy

dc.contributor.authorDurmuş, Ebubekir
dc.contributor.authorErsoy, Esma Ecem
dc.contributor.authorŞengün, Gözde Derin
dc.contributor.authorAykut, Veysel
dc.contributor.authorEsen, Fehim
dc.contributor.authorOğuz, Halit
dc.date.accessioned2025-11-16T19:26:41Z
dc.date.issued2025
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractPurpose: Pars plana vitrectomy (PPV) is typically reserved for refractory and complicated cases of diabetic vitreous hemorrhage (VH). However, no consensus guidelines are available for uncomplicated VH treatment. This study aimed to compare outcomes of medical versus surgical treatments for uncomplicated diabetic VH. Methods: We conducted a retrospective review of medical records for patients with diabetic VH, focusing on uncomplicated cases. Patients were assigned to medical and surgical groups (early and rescue PPV). The medical group treatments included observation only, intravitreal anti-VEGF injection, and panretinal photocoagulation (PRP), with PRP completed after VH resorption in all cases. The surgical groups underwent PPV or a preoperative single intravitreal anti-VEGF before PPV. Results: There were 34 patients in the medical group and 35 in the surgical groups (24 early PPV, 11 rescue PPV). Patients in the surgical group had longer VH duration, higher VH grade, and poorer baseline CDVA compared to medical group (p<0.01 each). CDVA significantly improved in all groups post-treatment. VH clearance rates were higher in the surgical group (90%±18 for early PPV, 88%±25 for rescue PPV) compared to the medical group (70%±22, p=0.001). Final CDVA did not significantly differ between medical and surgical subgroups (p=0.549). Recurrent VH was the predominant complication in both groups. Eight surgical patients had elevated IOP, with three developing glaucoma. Rescue PPV was required in 24.4% of initially medically treated patients. Conclusion: Medical management should be the initial approach for uncomplicated diabetic VH, while PPV should be considered for cases of persistent or severe VH.
dc.identifier.doi10.37845/ret.vit.2025.34.2
dc.identifier.endpage11
dc.identifier.issn1300-1256
dc.identifier.issn2717-7149
dc.identifier.issue1
dc.identifier.startpage5
dc.identifier.trdizinid1328887
dc.identifier.urihttps://doi.org/10.37845/ret.vit.2025.34.2
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1328887
dc.identifier.urihttps://hdl.handle.net/20.500.14730/14838
dc.identifier.volume34
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofRetina-Vitreus
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR-Dizin_20251116
dc.subjectPars plana vitrectomy
dc.subjectpanretinal photocoagulation
dc.subjectDiabetic vitreous hemorrhage
dc.subjectintravitreal anti-VEGF injection
dc.titleComparing Treatment Strategies for Uncomplicated Diabetic Vitreous Hemorrhage: Medical Therapy versus Early Pars Plana Vitrectomy
dc.typeOther

Dosyalar